Asia Pacific Biosurgery Market (2019-2025)
The Asia Pacific Biosurgery Market would witness market growth of 8.3% CAGR during the forecast period (2019-2025).
Biosurgery has also been labeled as maggot therapy or larva therapy. These maggots or larvae can heal chronically-infected wounds that resist antibiotics. A biosurgery procedure with maggot debridement therapy has proven to be effective for diabetic patients. The increased prevalence of diabetes and spinal injuries is expected to sustain the demand for biosurgery in the years to come. Additionally, biosurgery is also useful for neurological, orthopedic, and gynecology surgeries. This can substantially boost the product demand.
Increased demand for minimally invasive surgery alongside the continual rise in the geriatric population suffering from chronic conditions is projected to expand the biosurgery market. Biosurgery products can reduce the risks that might occur due to tissue contamination. This can significantly drive demand. Moreover, effective measures for blood loss during surgeries are likely to boost the adoption of these procedures over the forecast period.
The Asia Pacific (APAC) region is expected to emerge as a major region for biosurgery with the highest growth rate over the forecast period. Japan was one of the dominant countries in this region during 2018 because of its huge geriatric population and swift economic growth. Moreover, an increase in the awareness about the advanced surgical procedures is projected to boost the market growth during the forecast period.
Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
Scope of the Study
Market Segmentation:
By Application
Biosurgery has also been labeled as maggot therapy or larva therapy. These maggots or larvae can heal chronically-infected wounds that resist antibiotics. A biosurgery procedure with maggot debridement therapy has proven to be effective for diabetic patients. The increased prevalence of diabetes and spinal injuries is expected to sustain the demand for biosurgery in the years to come. Additionally, biosurgery is also useful for neurological, orthopedic, and gynecology surgeries. This can substantially boost the product demand.
Increased demand for minimally invasive surgery alongside the continual rise in the geriatric population suffering from chronic conditions is projected to expand the biosurgery market. Biosurgery products can reduce the risks that might occur due to tissue contamination. This can significantly drive demand. Moreover, effective measures for blood loss during surgeries are likely to boost the adoption of these procedures over the forecast period.
The Asia Pacific (APAC) region is expected to emerge as a major region for biosurgery with the highest growth rate over the forecast period. Japan was one of the dominant countries in this region during 2018 because of its huge geriatric population and swift economic growth. Moreover, an increase in the awareness about the advanced surgical procedures is projected to boost the market growth during the forecast period.
Based on Application, the market is segmented into General Surgeries, Orthopedic Surgeries, Neurological Surgeries, Cardiovascular Surgeries and Other Applications. Based on Product, the market is segmented into Surgical sealants, Soft Tissue Attachments, Adhesion Barriers, Hemostatic Agents, Bone Graft Substitutes and Other Products. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Johnson and Johnson, Medtronic PLC, Pfizer, Inc., Stryker Corporation, B. Braun Melsungen AG, Sanofi S.A., Becton, Dickinson and Company, Integra LifeSciences Holdings Corporation and CSL Limited.
Scope of the Study
Market Segmentation:
By Application
- General Surgeries
- Orthopedic Surgeries
- Neurological Surgeries
- Cardiovascular Surgeries
- Other Applications
- Surgical Sealants
- Soft Tissue Attachments
- Adhesion Barriers
- Hemostatic Agents
- Bone Graft Substitutes
- Other Products
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- Baxter International, Inc.
- Johnson and Johnson
- Medtronic PLC
- Pfizer, Inc.
- Stryker Corporation
- B. Braun Melsungen AG
- Sanofi S.A.
- Becton, Dickinson and Company
- Integra LifeSciences Holdings Corporation
- CSL Limited
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Biosurgery Market, by Application
1.4.2 Asia Pacific Biosurgery Market, by Product
1.4.3 Asia Pacific Biosurgery Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Dec – 2016-Apr) Leading Players
CHAPTER 4. ASIA PACIFIC BIOSURGERY MARKET BY APPLICATION
4.1 Asia Pacific General Surgeries Market by Country
4.2 Asia Pacific Orthopedic Surgeries Market by Country
4.3 Asia Pacific Neurological Surgeries Market by Country
4.4 Asia Pacific Cardiovascular Surgeries Market by Country
4.5 Asia Pacific Other Application Biosurgery Market by Country
CHAPTER 5. ASIA PACIFIC BIOSURGERY MARKET BY PRODUCT
5.1 Asia Pacific Surgical sealants Biosurgery Market by Country
5.2 Asia Pacific Soft Tissue Attachments Biosurgery Market by Country
5.3 Asia Pacific Adhesion Barriers Biosurgery Market by Country
5.4 Asia Pacific Hemostatic Agents Biosurgery Market by Country
5.5 Asia Pacific Bone Graft Substitutes Biosurgery Market by Country
5.6 Asia Pacific Others Biosurgery Market by Country
CHAPTER 6. ASIA PACIFIC BIOSURGERY MARKET BY COUNTRY
6.1 China Biosurgery Market
6.1.1 China Biosurgery Market by Application
6.1.2 China Biosurgery Market by Product
6.2 Japan Biosurgery Market
6.2.1 Japan Biosurgery Market by Application
6.2.2 Japan Biosurgery Market by Product
6.3 India Biosurgery Market
6.3.1 India Biosurgery Market by Application
6.3.2 India Biosurgery Market by Product
6.4 South Korea Biosurgery Market
6.4.1 South Korea Biosurgery Market by Application
6.4.2 South Korea Biosurgery Market by Product
6.5 Singapore Biosurgery Market
6.5.1 Singapore Biosurgery Market by Application
6.5.2 Singapore Biosurgery Market by Product
6.6 Malaysia Biosurgery Market
6.6.1 Malaysia Biosurgery Market by Application
6.6.2 Malaysia Biosurgery Market by Product
6.7 Rest of Asia Pacific Biosurgery Market
6.7.1 Rest of Asia Pacific Biosurgery Market by Application
6.7.2 Rest of Asia Pacific Biosurgery Market by Product
CHAPTER 7. COMPANY PROFILES
7.1 Baxter International, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Acquisition and Mergers:
7.2 Johnson and Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Medtronic PLC
7.3.1 Company overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Stryker Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Geographical Expansions:
7.8 Becton, Dickinson and Company
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.9 Integra LifeSciences Holdings Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 CSL Limited
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Biosurgery Market, by Application
1.4.2 Asia Pacific Biosurgery Market, by Product
1.4.3 Asia Pacific Biosurgery Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2019-Dec – 2016-Apr) Leading Players
CHAPTER 4. ASIA PACIFIC BIOSURGERY MARKET BY APPLICATION
4.1 Asia Pacific General Surgeries Market by Country
4.2 Asia Pacific Orthopedic Surgeries Market by Country
4.3 Asia Pacific Neurological Surgeries Market by Country
4.4 Asia Pacific Cardiovascular Surgeries Market by Country
4.5 Asia Pacific Other Application Biosurgery Market by Country
CHAPTER 5. ASIA PACIFIC BIOSURGERY MARKET BY PRODUCT
5.1 Asia Pacific Surgical sealants Biosurgery Market by Country
5.2 Asia Pacific Soft Tissue Attachments Biosurgery Market by Country
5.3 Asia Pacific Adhesion Barriers Biosurgery Market by Country
5.4 Asia Pacific Hemostatic Agents Biosurgery Market by Country
5.5 Asia Pacific Bone Graft Substitutes Biosurgery Market by Country
5.6 Asia Pacific Others Biosurgery Market by Country
CHAPTER 6. ASIA PACIFIC BIOSURGERY MARKET BY COUNTRY
6.1 China Biosurgery Market
6.1.1 China Biosurgery Market by Application
6.1.2 China Biosurgery Market by Product
6.2 Japan Biosurgery Market
6.2.1 Japan Biosurgery Market by Application
6.2.2 Japan Biosurgery Market by Product
6.3 India Biosurgery Market
6.3.1 India Biosurgery Market by Application
6.3.2 India Biosurgery Market by Product
6.4 South Korea Biosurgery Market
6.4.1 South Korea Biosurgery Market by Application
6.4.2 South Korea Biosurgery Market by Product
6.5 Singapore Biosurgery Market
6.5.1 Singapore Biosurgery Market by Application
6.5.2 Singapore Biosurgery Market by Product
6.6 Malaysia Biosurgery Market
6.6.1 Malaysia Biosurgery Market by Application
6.6.2 Malaysia Biosurgery Market by Product
6.7 Rest of Asia Pacific Biosurgery Market
6.7.1 Rest of Asia Pacific Biosurgery Market by Application
6.7.2 Rest of Asia Pacific Biosurgery Market by Product
CHAPTER 7. COMPANY PROFILES
7.1 Baxter International, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Acquisition and Mergers:
7.2 Johnson and Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Medtronic PLC
7.3.1 Company overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and Mergers:
7.5 Stryker Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 B. Braun Melsungen AG
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Geographical Expansions:
7.8 Becton, Dickinson and Company
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.9 Integra LifeSciences Holdings Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 CSL Limited
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
LIST OF TABLES
TABLE 1 ASIA PACIFIC BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 2 ASIA PACIFIC BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– BIOSURGERY MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– BIOSURGERY MARKET
TABLE 5 GEOGRAPHICAL EXPANSIONS– BIOSURGERY MARKET
TABLE 6 MERGERS & ACQUISITIONS – BIOSURGERY MARKET
TABLE 7 ASIA PACIFIC BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 8 ASIA PACIFIC BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 9 ASIA PACIFIC GENERAL SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 ASIA PACIFIC GENERAL SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 ASIA PACIFIC ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 ASIA PACIFIC ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 ASIA PACIFIC NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 ASIA PACIFIC NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 ASIA PACIFIC CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 ASIA PACIFIC CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 ASIA PACIFIC OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 ASIA PACIFIC OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 ASIA PACIFIC BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 20 ASIA PACIFIC BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 21 ASIA PACIFIC SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 ASIA PACIFIC SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 ASIA PACIFIC SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 ASIA PACIFIC SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 ASIA PACIFIC ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 ASIA PACIFIC ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 ASIA PACIFIC HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 ASIA PACIFIC HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 ASIA PACIFIC BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 ASIA PACIFIC BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 ASIA PACIFIC OTHERS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 ASIA PACIFIC OTHERS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 ASIA PACIFIC BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 ASIA PACIFIC BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 CHINA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 36 CHINA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 37 CHINA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 38 CHINA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 39 CHINA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 40 CHINA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 41 JAPAN BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 42 JAPAN BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 43 JAPAN BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 44 JAPAN BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 45 JAPAN BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 46 JAPAN BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 47 INDIA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 48 INDIA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 49 INDIA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 50 INDIA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 51 INDIA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 52 INDIA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 53 SOUTH KOREA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 54 SOUTH KOREA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 55 SOUTH KOREA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 56 SOUTH KOREA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 57 SOUTH KOREA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 58 SOUTH KOREA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 59 SINGAPORE BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 60 SINGAPORE BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 61 SINGAPORE BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 62 SINGAPORE BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 63 SINGAPORE BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 64 SINGAPORE BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 65 MALAYSIA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 66 MALAYSIA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 67 MALAYSIA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 68 MALAYSIA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 69 MALAYSIA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 70 MALAYSIA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 71 REST OF ASIA PACIFIC BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 72 REST OF ASIA PACIFIC BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 73 REST OF ASIA PACIFIC BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 74 REST OF ASIA PACIFIC BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 75 REST OF ASIA PACIFIC BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 76 REST OF ASIA PACIFIC BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 77 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 78 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 79 KEY INFORMATION – MEDTRONIC PLC
TABLE 80 KEY INFORMATION – PFIZER, INC.
TABLE 81 KEY INFORMATION – STRYKER CORPORATION
TABLE 82 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 83 KEY INFORMATION – SANOFI S.A.
TABLE 84 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 85 KEY INFORMATION – INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 86 KEY INFORMATION – CSL LIMITED
TABLE 1 ASIA PACIFIC BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 2 ASIA PACIFIC BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– BIOSURGERY MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– BIOSURGERY MARKET
TABLE 5 GEOGRAPHICAL EXPANSIONS– BIOSURGERY MARKET
TABLE 6 MERGERS & ACQUISITIONS – BIOSURGERY MARKET
TABLE 7 ASIA PACIFIC BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 8 ASIA PACIFIC BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 9 ASIA PACIFIC GENERAL SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 ASIA PACIFIC GENERAL SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 ASIA PACIFIC ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 ASIA PACIFIC ORTHOPEDIC SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 ASIA PACIFIC NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 ASIA PACIFIC NEUROLOGICAL SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 ASIA PACIFIC CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 ASIA PACIFIC CARDIOVASCULAR SURGERIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 ASIA PACIFIC OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 ASIA PACIFIC OTHER APPLICATION BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 ASIA PACIFIC BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 20 ASIA PACIFIC BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 21 ASIA PACIFIC SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 ASIA PACIFIC SURGICAL SEALANTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 ASIA PACIFIC SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 ASIA PACIFIC SOFT TISSUE ATTACHMENTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 ASIA PACIFIC ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 ASIA PACIFIC ADHESION BARRIERS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 ASIA PACIFIC HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 ASIA PACIFIC HEMOSTATIC AGENTS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 ASIA PACIFIC BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 ASIA PACIFIC BONE GRAFT SUBSTITUTES BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 ASIA PACIFIC OTHERS BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 ASIA PACIFIC OTHERS BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 ASIA PACIFIC BIOSURGERY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 ASIA PACIFIC BIOSURGERY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 CHINA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 36 CHINA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 37 CHINA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 38 CHINA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 39 CHINA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 40 CHINA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 41 JAPAN BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 42 JAPAN BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 43 JAPAN BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 44 JAPAN BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 45 JAPAN BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 46 JAPAN BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 47 INDIA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 48 INDIA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 49 INDIA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 50 INDIA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 51 INDIA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 52 INDIA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 53 SOUTH KOREA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 54 SOUTH KOREA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 55 SOUTH KOREA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 56 SOUTH KOREA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 57 SOUTH KOREA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 58 SOUTH KOREA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 59 SINGAPORE BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 60 SINGAPORE BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 61 SINGAPORE BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 62 SINGAPORE BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 63 SINGAPORE BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 64 SINGAPORE BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 65 MALAYSIA BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 66 MALAYSIA BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 67 MALAYSIA BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 68 MALAYSIA BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 69 MALAYSIA BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 70 MALAYSIA BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 71 REST OF ASIA PACIFIC BIOSURGERY MARKET, 2015 - 2018, USD MILLION
TABLE 72 REST OF ASIA PACIFIC BIOSURGERY MARKET, 2019 - 2025, USD MILLION
TABLE 73 REST OF ASIA PACIFIC BIOSURGERY MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 74 REST OF ASIA PACIFIC BIOSURGERY MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 75 REST OF ASIA PACIFIC BIOSURGERY MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 76 REST OF ASIA PACIFIC BIOSURGERY MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 77 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 78 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 79 KEY INFORMATION – MEDTRONIC PLC
TABLE 80 KEY INFORMATION – PFIZER, INC.
TABLE 81 KEY INFORMATION – STRYKER CORPORATION
TABLE 82 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 83 KEY INFORMATION – SANOFI S.A.
TABLE 84 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 85 KEY INFORMATION – INTEGRA LIFESCIENCES HOLDINGS CORPORATION
TABLE 86 KEY INFORMATION – CSL LIMITED
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-DEC – 2016-APR) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BAXTER INTERNATIONAL, INC.
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION AND MERGERS: 2019-DEC – 2016-APR) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BAXTER INTERNATIONAL, INC.
